艾司佐匹克隆治疗成人失眠的疗效和安全性：关于残留日间作用的无证据支持的观点。
Efficacy and safety of esmirtazapine in adult insomnia: unsupported statements about residual daytime effects.
机构信息
Sleep & Attention Disorders Institute, Sterling Heights, Michigan.
出版信息
J Clin Sleep Med. 2021 Feb 1;17(2):341. doi: 10.5664/jcsm.8912.
Abstract
Sangal RB. Efficacy and safety of esmirtazapine in adult insomnia: unsupported statements about residual daytime effects. 2021;17(2):341.
摘要
桑加尔 RB。依他佐辛治疗成人失眠的疗效和安全性：关于残留日间作用的未经证实的说法。2021;17(2):341.
相似文献
1
Efficacy and safety of esmirtazapine in adult insomnia: unsupported statements about residual daytime effects.艾司佐匹克隆治疗成人失眠的疗效和安全性：关于残留日间作用的无证据支持的观点。
J Clin Sleep Med. 2021 Feb 1;17(2):341. doi: 10.5664/jcsm.8912.
2
Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial.艾司米氮平治疗非老年原发性失眠成年患者：一项为期6周的随机睡眠实验室试验的疗效与安全性
Sleep Med. 2015 Jul;16(7):838-44. doi: 10.1016/j.sleep.2015.04.001. Epub 2015 Apr 16.
3
Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial.艾司米氮平治疗非老年原发性失眠成年患者：一项为期2周的随机门诊试验的疗效与安全性
Sleep Med. 2015 Jul;16(7):831-7. doi: 10.1016/j.sleep.2015.03.005. Epub 2015 Mar 30.
4
Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study and open-label extension.米氮平治疗成年慢性原发性失眠门诊患者的疗效与安全性：一项随机、双盲、安慰剂对照研究及开放标签延长期研究
J Clin Sleep Med. 2020 Sep 15;16(9):1455-1467. doi: 10.5664/jcsm.8526.
5
A Phase 2 Randomized Dose-Finding Study With Esmirtazapine in Patients With Primary Insomnia.一项使用艾司米氮平治疗原发性失眠患者的2期随机剂量探索研究。
J Clin Psychopharmacol. 2016 Oct;36(5):457-64. doi: 10.1097/JCP.0000000000000546.
6
Residual daytime effects of esmirtazapine.依他扎哌隆残留日间效应。
J Clin Sleep Med. 2021 Apr 1;17(4):865. doi: 10.5664/jcsm.9120.
7
[Clinical Problems before Initiating Pharmacotherapy for Insomnia].[失眠药物治疗开始前的临床问题]
Seishin Shinkeigaku Zasshi. 2015;117(4):277-82.
8
Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype.依他扎哌隆对实际驾驶表现的残留效应：总体发现与 CYP2D6 表型作用之探索性分析。
Psychopharmacology (Berl). 2011 May;215(2):321-32. doi: 10.1007/s00213-010-2149-4. Epub 2011 Jan 19.
9
Review of Safety and Efficacy of Sleep Medicines in Older Adults.老年人睡眠药物的安全性与有效性综述。
Clin Ther. 2016 Nov;38(11):2340-2372. doi: 10.1016/j.clinthera.2016.09.010. Epub 2016 Oct 15.
10
Pharmacological intervention in slow-wave sleep: a novel approach to the management of insomnia?慢波睡眠的药理学干预：一种治疗失眠的新方法？
World J Biol Psychiatry. 2010 Jun;11 Suppl 1:29-30. doi: 10.3109/15622971003637702.
引用本文的文献
1
Residual daytime effects of esmirtazapine.依他扎哌隆残留日间效应。
J Clin Sleep Med. 2021 Apr 1;17(4):865. doi: 10.5664/jcsm.9120.
本文引用的文献
1
Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study and open-label extension.米氮平治疗成年慢性原发性失眠门诊患者的疗效与安全性：一项随机、双盲、安慰剂对照研究及开放标签延长期研究
J Clin Sleep Med. 2020 Sep 15;16(9):1455-1467. doi: 10.5664/jcsm.8526.
2
Baseline Lighter Sleep and Lower Saturation Are Associated With Improved Sleepiness and Adherence on Continuous Rather Than Autotitrating Positive Airway Pressure.基线时较轻的睡眠和较低的饱和度与连续而非自动滴定正压通气治疗时嗜睡的改善和依从性提高相关。
Clin EEG Neurosci. 2020 May;51(3):174-179. doi: 10.1177/1550059419892759. Epub 2019 Dec 18.
3
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials.苏沃雷生治疗失眠症患者的疗效：两项为期 3 个月的随机对照临床试验结果。
Biol Psychiatry. 2016 Jan 15;79(2):136-48. doi: 10.1016/j.biopsych.2014.10.003. Epub 2014 Oct 23.
4
Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study.在伴有和不伴有合并精神疾病的老年和非老年慢性失眠日本患者中，eszopiclone 对安全性、主观疗效测量和生活质量的影响：一项 24 周、随机、双盲研究。
Ann Gen Psychiatry. 2012 Jun 25;11(1):15. doi: 10.1186/1744-859X-11-15.
5
Trazodone increases arousal threshold in obstructive sleep apnoea.曲唑酮可提高阻塞性睡眠呼吸暂停的唤醒阈值。
Eur Respir J. 2008 Jun;31(6):1308-12. doi: 10.1183/09031936.00067607. Epub 2008 Feb 6.
6
7
Clinical pharmacokinetics of mirtazapine.米氮平的临床药代动力学
Clin Pharmacokinet. 2000 Jun;38(6):461-74. doi: 10.2165/00003088-200038060-00001.
8
Trazodone (Desyrel, Mead-Johnson Pharmaceutical Division).曲唑酮（安适定，美赞臣制药部）。
Drug Intell Clin Pharm. 1982 Jan;16(1):7-13. doi: 10.1177/106002808201600102.
Zotero 插件